[go: up one dir, main page]

MX9306016A - Metodo para incrementar respuestas inmunes mediadas por celulas. - Google Patents

Metodo para incrementar respuestas inmunes mediadas por celulas.

Info

Publication number
MX9306016A
MX9306016A MX9306016A MX9306016A MX9306016A MX 9306016 A MX9306016 A MX 9306016A MX 9306016 A MX9306016 A MX 9306016A MX 9306016 A MX9306016 A MX 9306016A MX 9306016 A MX9306016 A MX 9306016A
Authority
MX
Mexico
Prior art keywords
cells
immune responses
responses mediated
increase immune
immunogen
Prior art date
Application number
MX9306016A
Other languages
English (en)
Inventor
Balbir S Bhogal
Krishnaswamy I Dayalu
Jay D Gerber
Original Assignee
Smithkline Beechman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beechman Corp filed Critical Smithkline Beechman Corp
Publication of MX9306016A publication Critical patent/MX9306016A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

Un método para incrementar una respuesta inmune mediada por célulasespecíficas, preferiblemente en cerdos, que incluye vacunar a animaleshembras con un inmunógeno de Mycoplasma, de modo que la vacunaciónsubsecuente del recién nacido con el mismo inmunógeno estimula unarespuesta inmune mediada por células en comparación con recién nacidos demadres no vacunadas.
MX9306016A 1992-09-28 1993-09-28 Metodo para incrementar respuestas inmunes mediadas por celulas. MX9306016A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95224892A 1992-09-28 1992-09-28

Publications (1)

Publication Number Publication Date
MX9306016A true MX9306016A (es) 1995-01-31

Family

ID=25492700

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306016A MX9306016A (es) 1992-09-28 1993-09-28 Metodo para incrementar respuestas inmunes mediadas por celulas.

Country Status (11)

Country Link
EP (1) EP0839050B1 (es)
JP (1) JPH08502253A (es)
AT (1) ATE273022T1 (es)
AU (1) AU687750B2 (es)
CA (1) CA2145760A1 (es)
DE (1) DE69333588T2 (es)
DK (1) DK0839050T3 (es)
ES (1) ES2225825T3 (es)
MX (1) MX9306016A (es)
PT (1) PT839050E (es)
WO (1) WO1994007531A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4658423B2 (ja) 1999-08-03 2011-03-23 ザ オハイオ ステイト ユニバーシティ Ｈｅｒ−２タンパク質に対する免疫反応性を増強するためのポリペプチドおよびポリヌクレオチド
ES2312580T5 (es) * 2001-07-02 2017-12-11 Zoetis Services Llc Vacunación en dosis única con l Mycoplasma hyopneumoniae /l
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
ES2531483T3 (es) 2005-06-15 2015-03-16 The Ohio State University Research Foundation Péptidos HER-2
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US8398970B2 (en) 2007-09-17 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early Lawsonia intracellularis infections
US20100234283A1 (en) 2009-02-04 2010-09-16 The Ohio State University Research Foundation Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use
EP2569007B1 (en) 2010-05-11 2015-10-14 Intervet International B.V. Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
US4985243A (en) * 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
JP3187419B2 (ja) * 1990-05-29 2001-07-11 アメリカン・サイアナミド・カンパニー ブタ肺炎ワクチンおよびその製造方法
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof

Also Published As

Publication number Publication date
AU687750B2 (en) 1998-03-05
DE69333588T2 (de) 2005-08-04
AU4931293A (en) 1994-04-26
DK0839050T3 (da) 2004-10-25
CA2145760A1 (en) 1994-04-14
JPH08502253A (ja) 1996-03-12
PT839050E (pt) 2004-11-30
WO1994007531A1 (en) 1994-04-14
EP0839050A4 (es) 1998-05-06
EP0839050B1 (en) 2004-08-11
DE69333588D1 (de) 2004-09-16
EP0839050A1 (en) 1998-05-06
ES2225825T3 (es) 2005-03-16
ATE273022T1 (de) 2004-08-15

Similar Documents

Publication Publication Date Title
ZA91559B (en) Vaccines against cancer and infectious diseases
FI943171A0 (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
DE3486293D1 (de) Impfstoff-Zubereitung.
BR9106748A (pt) Vacina de hyopneumomiae micoplasma inativado e metodo de seu uso
DK450183A (da) Humane monoklone antistoffer mod et bakterietoksin samt disses fremstilling, kontinuerlige cellelinier, som producerer antitoksin-antistoffer, samt antistoffernes anvendelser
NO950739D0 (no) Vaksiner mot gruppe C Neisseria Meningtidis
ES537459A0 (es) Procedimiento para preparar anticuerpos anti-idiotipicos
MX9306016A (es) Metodo para incrementar respuestas inmunes mediadas por celulas.
DE2967036D1 (en) Vaccine and method of making
DK16087D0 (da) Mastitis-vaccine
DE68917138D1 (de) Toleranzinduktion gegenüber einem fremdantigen.
BR9306187A (pt) Vacina bacterin-toxóide pasteurella haemolytica tipo a-1
Toma et al. Vaccination of dogs against rabies. Comparison of serological responses one year after intradermal or subcutaneous vaccination
ES2059605T3 (es) Vacuna toxoide de la tosferina.
Kraaijeveld et al. Delayed type hypersensitivity against semliki forest virus in mice: local transfer of delayed type hypersensitivity with thioglycollate-induced peritoneal exudate cells
NZ212274A (en) Method of producing anti-male antibodies, antibodies so produced and lymphocytes
ATE136901T1 (de) Antigen gegen diabetes
Zheng et al. Studies on the biological properties of a chemical vaccine prepared from antigenic fractions of Vibrio cholerae.
Truijen et al. Aujeszky's disease: maternal immunity of piglets born of sows inoculated with various vaccines (author's transl)
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
Griffin The development and clinical testing of an anti-HCG vaccine based on a synthetic peptide of the beta-HCG carboxyterminal
Wang Studies on the biological properties of avirulent Rickettsia prowazekii Madrid E.
Dong et al. Preparation of various cholera vaccines and comparison of their immuno-effect.
JPS6423893A (en) Method for cell fusion